Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harish Kumar

Showing results (681-690 of 703) with videos related to

Pageof 71
Sort By:
Molecular and Cellular Endocrinology|December 2, 2021
Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expressionSourav Chattopadhyay, Amit Joharapurkar, Nabanita Das, et al.
One Health (Amsterdam, Netherlands)|March 24, 2025
Challenges and opportunities for AMR research in the ASEAN following the One Health approachHarish Kumar Tiwari, Daniel K Y Tan, Chhe Chinda, et al.
Science Translational Medicine|August 6, 2025
Activation of a nongenetic AHR-ELMSAN1 axis optimizes BET-targeting therapy and suppresses leukemia stem cells in preclinical modelsXinyue Zhou, Steven Moreira, Cecilia Restelli, et al.
Therapeutic Advances in Infectious Disease|October 8, 2025
Mpox: transmission dynamics, treatment, and innovationsPrakasini Satapathy, Beema T Yoosuf, Abhay M Gaidhane, et al.
The Journal of the Association of Physicians of India|March 12, 2026
A Prospective Real-world Study to Assess Safety, Tolerability, and Effectiveness of Imeglimin among People with Type 2 Diabetes Mellitus Who are Intolerant to Metformin (PRISM Study)Prabhat Kumar Agrawal, Ketan K Mehta, Abhisekh Raha, et al.
The Journal of Comparative Neurology|April 9, 2024
Histological characterization and development of mesial surface sulci in the human brain at 13-15 gestational weeks through high-resolution histologyRicha Verma, Jaikishan Jayakumar, Rebecca Folkerth, et al.
Pharmacology|November 23, 2021
Pregnane-Oximino-Alkyl-Amino-Ether Compound as a Novel Class of TGR5 Receptor Agonist Exhibiting Antidiabetic and Anti-Dyslipidemic ActivitiesJyoti Gupta, Dharmendra P Singh, Prem C Verma, et al.
American Journal of Ophthalmology|February 22, 2025
Diagnostic Accuracy of IDX-DR for Detecting Diabetic Retinopathy: A Systematic Review and Meta-AnalysisZaid Khan, Abhay M Gaidhane, Mahendra Singh, et al.
Diabetes|October 7, 2017
Erratum. Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1α and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced Osteopenia. Diabetes 2015;64:2609-2623Mohd Parvez Khan, Abhishek Kumar Singh, Amit Arvind Joharapurkar, et al.
Diabetes|January 31, 2015
Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1α and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced OsteopeniaMohd Parvez Khan, Abhishek Kumar Singh, Amit Arvind Joharapurkar, et al.
Pageof 71

Showing results (681-690 of 703) with videos related to

Sort By:
Pageof 71
Molecular and Cellular Endocrinology|December 2, 2021
Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expressionSourav Chattopadhyay, Amit Joharapurkar, Nabanita Das, et al.
One Health (Amsterdam, Netherlands)|March 24, 2025
Challenges and opportunities for AMR research in the ASEAN following the One Health approachHarish Kumar Tiwari, Daniel K Y Tan, Chhe Chinda, et al.
Science Translational Medicine|August 6, 2025
Activation of a nongenetic AHR-ELMSAN1 axis optimizes BET-targeting therapy and suppresses leukemia stem cells in preclinical modelsXinyue Zhou, Steven Moreira, Cecilia Restelli, et al.
Therapeutic Advances in Infectious Disease|October 8, 2025
Mpox: transmission dynamics, treatment, and innovationsPrakasini Satapathy, Beema T Yoosuf, Abhay M Gaidhane, et al.
The Journal of the Association of Physicians of India|March 12, 2026
A Prospective Real-world Study to Assess Safety, Tolerability, and Effectiveness of Imeglimin among People with Type 2 Diabetes Mellitus Who are Intolerant to Metformin (PRISM Study)Prabhat Kumar Agrawal, Ketan K Mehta, Abhisekh Raha, et al.
The Journal of Comparative Neurology|April 9, 2024
Histological characterization and development of mesial surface sulci in the human brain at 13-15 gestational weeks through high-resolution histologyRicha Verma, Jaikishan Jayakumar, Rebecca Folkerth, et al.
Pharmacology|November 23, 2021
Pregnane-Oximino-Alkyl-Amino-Ether Compound as a Novel Class of TGR5 Receptor Agonist Exhibiting Antidiabetic and Anti-Dyslipidemic ActivitiesJyoti Gupta, Dharmendra P Singh, Prem C Verma, et al.
American Journal of Ophthalmology|February 22, 2025
Diagnostic Accuracy of IDX-DR for Detecting Diabetic Retinopathy: A Systematic Review and Meta-AnalysisZaid Khan, Abhay M Gaidhane, Mahendra Singh, et al.
Diabetes|October 7, 2017
Erratum. Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1α and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced Osteopenia. Diabetes 2015;64:2609-2623Mohd Parvez Khan, Abhishek Kumar Singh, Amit Arvind Joharapurkar, et al.
Diabetes|January 31, 2015
Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1α and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced OsteopeniaMohd Parvez Khan, Abhishek Kumar Singh, Amit Arvind Joharapurkar, et al.
Pageof 71